Exane BNP Paribas analyst Rob Jones upgraded Gecina to Outperform from Neutral with a EUR 120 price target. The analyst sees the stock as undervalued following the recent underperformance.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GECFF: